Type 1 Diabetes and Use of ‘Off-Label’ Drugs: Benefits, but Concerns, Too
MONDAY, Feb. 20, 2023 (HealthDay News) — While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study. Type 1 diabetes is universally treated with insulin injections, but only aboutContinue Reading